Home / Inspections / 1312270

FDA Inspection 1312270 — South Florida Institute for Reproductive Medicine

South Florida Institute for Reproductive Medicine — FEI 3007787718

The FDA completed an inspection of South Florida Institute for Reproductive Medicine on April 6, 2026 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 6, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Naples, FL (United States)

Facility

Other inspections at this facility

  • 1204459 (NAI Wed Apr 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1151264 (NAI Wed Sep 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1029066 (NAI Mon Aug 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 717775 (NAI Thu Mar 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources